De acuerdo al tratamiento, se puede aplicar desde 0.6 mg por da e ir incrementando la dosis de forma semanal, de acuerdo a la indicacin mdica
In June 2021, the FDA approved a higher-dose formulation of semaglutidemarketed under the brand name Wegovyspecifically for chronic weight management in adults with obesity or those who are overweight and have at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol
Lowered Risk of Heart Disease
It supports every cell in the body, no matter who you are
Dr Lim Chong Wei, an endocrinology, diabetes and internal medicine specialist at Sunway Medical Centre, clarified that semaglutide was originally approved as a weekly injection for Type 2 diabetes, typically combined with the right diet and exercise